Global Amivantamab Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Amivantamab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Amivantamab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Amivantamab market in any manner.
Global Amivantamab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ProteoGenix
Thermo Fisher Scientific
AntibodySystem SAS
Wuhan Chemstan Biotechnology
Biochempartner
Market Segmentation (by Type)
0 - 100ug
100ug - 1mg
Above 1mg
Market Segmentation (by Application)
Pharmaceutics
Clinical Testing
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Amivantamab Market
%li%Overview of the regional outlook of the Amivantamab Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Amivantamab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Amivantamab market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Amivantamab Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Amivantamab market in any manner.
Global Amivantamab Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
ProteoGenix
Thermo Fisher Scientific
AntibodySystem SAS
Wuhan Chemstan Biotechnology
Biochempartner
Market Segmentation (by Type)
0 - 100ug
100ug - 1mg
Above 1mg
Market Segmentation (by Application)
Pharmaceutics
Clinical Testing
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Amivantamab Market
%li%Overview of the regional outlook of the Amivantamab Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Amivantamab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Amivantamab
1.2 Key Market Segments
1.2.1 Amivantamab Segment by Type
1.2.2 Amivantamab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AMIVANTAMAB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Amivantamab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Amivantamab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AMIVANTAMAB MARKET COMPETITIVE LANDSCAPE
3.1 Global Amivantamab Sales by Manufacturers (2019-2024)
3.2 Global Amivantamab Revenue Market Share by Manufacturers (2019-2024)
3.3 Amivantamab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Amivantamab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Amivantamab Sales Sites, Area Served, Product Type
3.6 Amivantamab Market Competitive Situation and Trends
3.6.1 Amivantamab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Amivantamab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AMIVANTAMAB INDUSTRY CHAIN ANALYSIS
4.1 Amivantamab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AMIVANTAMAB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AMIVANTAMAB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Amivantamab Sales Market Share by Type (2019-2024)
6.3 Global Amivantamab Market Size Market Share by Type (2019-2024)
6.4 Global Amivantamab Price by Type (2019-2024)
7 AMIVANTAMAB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Amivantamab Market Sales by Application (2019-2024)
7.3 Global Amivantamab Market Size (M USD) by Application (2019-2024)
7.4 Global Amivantamab Sales Growth Rate by Application (2019-2024)
8 AMIVANTAMAB MARKET SEGMENTATION BY REGION
8.1 Global Amivantamab Sales by Region
8.1.1 Global Amivantamab Sales by Region
8.1.2 Global Amivantamab Sales Market Share by Region
8.2 North America
8.2.1 North America Amivantamab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Amivantamab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Amivantamab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Amivantamab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Amivantamab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ProteoGenix
9.1.1 ProteoGenix Amivantamab Basic Information
9.1.2 ProteoGenix Amivantamab Product Overview
9.1.3 ProteoGenix Amivantamab Product Market Performance
9.1.4 ProteoGenix Business Overview
9.1.5 ProteoGenix Amivantamab SWOT Analysis
9.1.6 ProteoGenix Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Amivantamab Basic Information
9.2.2 Thermo Fisher Scientific Amivantamab Product Overview
9.2.3 Thermo Fisher Scientific Amivantamab Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific Amivantamab SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 AntibodySystem SAS
9.3.1 AntibodySystem SAS Amivantamab Basic Information
9.3.2 AntibodySystem SAS Amivantamab Product Overview
9.3.3 AntibodySystem SAS Amivantamab Product Market Performance
9.3.4 AntibodySystem SAS Amivantamab SWOT Analysis
9.3.5 AntibodySystem SAS Business Overview
9.3.6 AntibodySystem SAS Recent Developments
9.4 Wuhan Chemstan Biotechnology
9.4.1 Wuhan Chemstan Biotechnology Amivantamab Basic Information
9.4.2 Wuhan Chemstan Biotechnology Amivantamab Product Overview
9.4.3 Wuhan Chemstan Biotechnology Amivantamab Product Market Performance
9.4.4 Wuhan Chemstan Biotechnology Business Overview
9.4.5 Wuhan Chemstan Biotechnology Recent Developments
9.5 Biochempartner
9.5.1 Biochempartner Amivantamab Basic Information
9.5.2 Biochempartner Amivantamab Product Overview
9.5.3 Biochempartner Amivantamab Product Market Performance
9.5.4 Biochempartner Business Overview
9.5.5 Biochempartner Recent Developments
10 AMIVANTAMAB MARKET FORECAST BY REGION
10.1 Global Amivantamab Market Size Forecast
10.2 Global Amivantamab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Amivantamab Market Size Forecast by Country
10.2.3 Asia Pacific Amivantamab Market Size Forecast by Region
10.2.4 South America Amivantamab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Amivantamab by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Amivantamab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Amivantamab by Type (2025-2030)
11.1.2 Global Amivantamab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Amivantamab by Type (2025-2030)
11.2 Global Amivantamab Market Forecast by Application (2025-2030)
11.2.1 Global Amivantamab Sales (Kilotons) Forecast by Application
11.2.2 Global Amivantamab Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Amivantamab
1.2 Key Market Segments
1.2.1 Amivantamab Segment by Type
1.2.2 Amivantamab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AMIVANTAMAB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Amivantamab Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Amivantamab Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AMIVANTAMAB MARKET COMPETITIVE LANDSCAPE
3.1 Global Amivantamab Sales by Manufacturers (2019-2024)
3.2 Global Amivantamab Revenue Market Share by Manufacturers (2019-2024)
3.3 Amivantamab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Amivantamab Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Amivantamab Sales Sites, Area Served, Product Type
3.6 Amivantamab Market Competitive Situation and Trends
3.6.1 Amivantamab Market Concentration Rate
3.6.2 Global 5 and 10 Largest Amivantamab Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AMIVANTAMAB INDUSTRY CHAIN ANALYSIS
4.1 Amivantamab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AMIVANTAMAB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AMIVANTAMAB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Amivantamab Sales Market Share by Type (2019-2024)
6.3 Global Amivantamab Market Size Market Share by Type (2019-2024)
6.4 Global Amivantamab Price by Type (2019-2024)
7 AMIVANTAMAB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Amivantamab Market Sales by Application (2019-2024)
7.3 Global Amivantamab Market Size (M USD) by Application (2019-2024)
7.4 Global Amivantamab Sales Growth Rate by Application (2019-2024)
8 AMIVANTAMAB MARKET SEGMENTATION BY REGION
8.1 Global Amivantamab Sales by Region
8.1.1 Global Amivantamab Sales by Region
8.1.2 Global Amivantamab Sales Market Share by Region
8.2 North America
8.2.1 North America Amivantamab Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Amivantamab Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Amivantamab Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Amivantamab Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Amivantamab Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 ProteoGenix
9.1.1 ProteoGenix Amivantamab Basic Information
9.1.2 ProteoGenix Amivantamab Product Overview
9.1.3 ProteoGenix Amivantamab Product Market Performance
9.1.4 ProteoGenix Business Overview
9.1.5 ProteoGenix Amivantamab SWOT Analysis
9.1.6 ProteoGenix Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Amivantamab Basic Information
9.2.2 Thermo Fisher Scientific Amivantamab Product Overview
9.2.3 Thermo Fisher Scientific Amivantamab Product Market Performance
9.2.4 Thermo Fisher Scientific Business Overview
9.2.5 Thermo Fisher Scientific Amivantamab SWOT Analysis
9.2.6 Thermo Fisher Scientific Recent Developments
9.3 AntibodySystem SAS
9.3.1 AntibodySystem SAS Amivantamab Basic Information
9.3.2 AntibodySystem SAS Amivantamab Product Overview
9.3.3 AntibodySystem SAS Amivantamab Product Market Performance
9.3.4 AntibodySystem SAS Amivantamab SWOT Analysis
9.3.5 AntibodySystem SAS Business Overview
9.3.6 AntibodySystem SAS Recent Developments
9.4 Wuhan Chemstan Biotechnology
9.4.1 Wuhan Chemstan Biotechnology Amivantamab Basic Information
9.4.2 Wuhan Chemstan Biotechnology Amivantamab Product Overview
9.4.3 Wuhan Chemstan Biotechnology Amivantamab Product Market Performance
9.4.4 Wuhan Chemstan Biotechnology Business Overview
9.4.5 Wuhan Chemstan Biotechnology Recent Developments
9.5 Biochempartner
9.5.1 Biochempartner Amivantamab Basic Information
9.5.2 Biochempartner Amivantamab Product Overview
9.5.3 Biochempartner Amivantamab Product Market Performance
9.5.4 Biochempartner Business Overview
9.5.5 Biochempartner Recent Developments
10 AMIVANTAMAB MARKET FORECAST BY REGION
10.1 Global Amivantamab Market Size Forecast
10.2 Global Amivantamab Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Amivantamab Market Size Forecast by Country
10.2.3 Asia Pacific Amivantamab Market Size Forecast by Region
10.2.4 South America Amivantamab Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Amivantamab by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Amivantamab Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Amivantamab by Type (2025-2030)
11.1.2 Global Amivantamab Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Amivantamab by Type (2025-2030)
11.2 Global Amivantamab Market Forecast by Application (2025-2030)
11.2.1 Global Amivantamab Sales (Kilotons) Forecast by Application
11.2.2 Global Amivantamab Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Amivantamab Market Size Comparison by Region (M USD)
Table 5. Global Amivantamab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Amivantamab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Amivantamab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Amivantamab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amivantamab as of 2022)
Table 10. Global Market Amivantamab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Amivantamab Sales Sites and Area Served
Table 12. Manufacturers Amivantamab Product Type
Table 13. Global Amivantamab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Amivantamab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Amivantamab Market Challenges
Table 22. Global Amivantamab Sales by Type (Kilotons)
Table 23. Global Amivantamab Market Size by Type (M USD)
Table 24. Global Amivantamab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Amivantamab Sales Market Share by Type (2019-2024)
Table 26. Global Amivantamab Market Size (M USD) by Type (2019-2024)
Table 27. Global Amivantamab Market Size Share by Type (2019-2024)
Table 28. Global Amivantamab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Amivantamab Sales (Kilotons) by Application
Table 30. Global Amivantamab Market Size by Application
Table 31. Global Amivantamab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Amivantamab Sales Market Share by Application (2019-2024)
Table 33. Global Amivantamab Sales by Application (2019-2024) & (M USD)
Table 34. Global Amivantamab Market Share by Application (2019-2024)
Table 35. Global Amivantamab Sales Growth Rate by Application (2019-2024)
Table 36. Global Amivantamab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Amivantamab Sales Market Share by Region (2019-2024)
Table 38. North America Amivantamab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Amivantamab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Amivantamab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Amivantamab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Amivantamab Sales by Region (2019-2024) & (Kilotons)
Table 43. ProteoGenix Amivantamab Basic Information
Table 44. ProteoGenix Amivantamab Product Overview
Table 45. ProteoGenix Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. ProteoGenix Business Overview
Table 47. ProteoGenix Amivantamab SWOT Analysis
Table 48. ProteoGenix Recent Developments
Table 49. Thermo Fisher Scientific Amivantamab Basic Information
Table 50. Thermo Fisher Scientific Amivantamab Product Overview
Table 51. Thermo Fisher Scientific Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Amivantamab SWOT Analysis
Table 54. Thermo Fisher Scientific Recent Developments
Table 55. AntibodySystem SAS Amivantamab Basic Information
Table 56. AntibodySystem SAS Amivantamab Product Overview
Table 57. AntibodySystem SAS Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AntibodySystem SAS Amivantamab SWOT Analysis
Table 59. AntibodySystem SAS Business Overview
Table 60. AntibodySystem SAS Recent Developments
Table 61. Wuhan Chemstan Biotechnology Amivantamab Basic Information
Table 62. Wuhan Chemstan Biotechnology Amivantamab Product Overview
Table 63. Wuhan Chemstan Biotechnology Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Wuhan Chemstan Biotechnology Business Overview
Table 65. Wuhan Chemstan Biotechnology Recent Developments
Table 66. Biochempartner Amivantamab Basic Information
Table 67. Biochempartner Amivantamab Product Overview
Table 68. Biochempartner Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Biochempartner Business Overview
Table 70. Biochempartner Recent Developments
Table 71. Global Amivantamab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global Amivantamab Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Amivantamab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America Amivantamab Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Amivantamab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe Amivantamab Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Amivantamab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific Amivantamab Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Amivantamab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America Amivantamab Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Amivantamab Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Amivantamab Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Amivantamab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global Amivantamab Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Amivantamab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global Amivantamab Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global Amivantamab Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Amivantamab Market Size Comparison by Region (M USD)
Table 5. Global Amivantamab Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Amivantamab Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Amivantamab Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Amivantamab Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amivantamab as of 2022)
Table 10. Global Market Amivantamab Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Amivantamab Sales Sites and Area Served
Table 12. Manufacturers Amivantamab Product Type
Table 13. Global Amivantamab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Amivantamab
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Amivantamab Market Challenges
Table 22. Global Amivantamab Sales by Type (Kilotons)
Table 23. Global Amivantamab Market Size by Type (M USD)
Table 24. Global Amivantamab Sales (Kilotons) by Type (2019-2024)
Table 25. Global Amivantamab Sales Market Share by Type (2019-2024)
Table 26. Global Amivantamab Market Size (M USD) by Type (2019-2024)
Table 27. Global Amivantamab Market Size Share by Type (2019-2024)
Table 28. Global Amivantamab Price (USD/Ton) by Type (2019-2024)
Table 29. Global Amivantamab Sales (Kilotons) by Application
Table 30. Global Amivantamab Market Size by Application
Table 31. Global Amivantamab Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Amivantamab Sales Market Share by Application (2019-2024)
Table 33. Global Amivantamab Sales by Application (2019-2024) & (M USD)
Table 34. Global Amivantamab Market Share by Application (2019-2024)
Table 35. Global Amivantamab Sales Growth Rate by Application (2019-2024)
Table 36. Global Amivantamab Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Amivantamab Sales Market Share by Region (2019-2024)
Table 38. North America Amivantamab Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Amivantamab Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Amivantamab Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Amivantamab Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Amivantamab Sales by Region (2019-2024) & (Kilotons)
Table 43. ProteoGenix Amivantamab Basic Information
Table 44. ProteoGenix Amivantamab Product Overview
Table 45. ProteoGenix Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. ProteoGenix Business Overview
Table 47. ProteoGenix Amivantamab SWOT Analysis
Table 48. ProteoGenix Recent Developments
Table 49. Thermo Fisher Scientific Amivantamab Basic Information
Table 50. Thermo Fisher Scientific Amivantamab Product Overview
Table 51. Thermo Fisher Scientific Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Amivantamab SWOT Analysis
Table 54. Thermo Fisher Scientific Recent Developments
Table 55. AntibodySystem SAS Amivantamab Basic Information
Table 56. AntibodySystem SAS Amivantamab Product Overview
Table 57. AntibodySystem SAS Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AntibodySystem SAS Amivantamab SWOT Analysis
Table 59. AntibodySystem SAS Business Overview
Table 60. AntibodySystem SAS Recent Developments
Table 61. Wuhan Chemstan Biotechnology Amivantamab Basic Information
Table 62. Wuhan Chemstan Biotechnology Amivantamab Product Overview
Table 63. Wuhan Chemstan Biotechnology Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Wuhan Chemstan Biotechnology Business Overview
Table 65. Wuhan Chemstan Biotechnology Recent Developments
Table 66. Biochempartner Amivantamab Basic Information
Table 67. Biochempartner Amivantamab Product Overview
Table 68. Biochempartner Amivantamab Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Biochempartner Business Overview
Table 70. Biochempartner Recent Developments
Table 71. Global Amivantamab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 72. Global Amivantamab Market Size Forecast by Region (2025-2030) & (M USD)
Table 73. North America Amivantamab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 74. North America Amivantamab Market Size Forecast by Country (2025-2030) & (M USD)
Table 75. Europe Amivantamab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 76. Europe Amivantamab Market Size Forecast by Country (2025-2030) & (M USD)
Table 77. Asia Pacific Amivantamab Sales Forecast by Region (2025-2030) & (Kilotons)
Table 78. Asia Pacific Amivantamab Market Size Forecast by Region (2025-2030) & (M USD)
Table 79. South America Amivantamab Sales Forecast by Country (2025-2030) & (Kilotons)
Table 80. South America Amivantamab Market Size Forecast by Country (2025-2030) & (M USD)
Table 81. Middle East and Africa Amivantamab Consumption Forecast by Country (2025-2030) & (Units)
Table 82. Middle East and Africa Amivantamab Market Size Forecast by Country (2025-2030) & (M USD)
Table 83. Global Amivantamab Sales Forecast by Type (2025-2030) & (Kilotons)
Table 84. Global Amivantamab Market Size Forecast by Type (2025-2030) & (M USD)
Table 85. Global Amivantamab Price Forecast by Type (2025-2030) & (USD/Ton)
Table 86. Global Amivantamab Sales (Kilotons) Forecast by Application (2025-2030)
Table 87. Global Amivantamab Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Amivantamab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Amivantamab Market Size (M USD), 2019-2030
Figure 5. Global Amivantamab Market Size (M USD) (2019-2030)
Figure 6. Global Amivantamab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Amivantamab Market Size by Country (M USD)
Figure 11. Amivantamab Sales Share by Manufacturers in 2023
Figure 12. Global Amivantamab Revenue Share by Manufacturers in 2023
Figure 13. Amivantamab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Amivantamab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Amivantamab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Amivantamab Market Share by Type
Figure 18. Sales Market Share of Amivantamab by Type (2019-2024)
Figure 19. Sales Market Share of Amivantamab by Type in 2023
Figure 20. Market Size Share of Amivantamab by Type (2019-2024)
Figure 21. Market Size Market Share of Amivantamab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Amivantamab Market Share by Application
Figure 24. Global Amivantamab Sales Market Share by Application (2019-2024)
Figure 25. Global Amivantamab Sales Market Share by Application in 2023
Figure 26. Global Amivantamab Market Share by Application (2019-2024)
Figure 27. Global Amivantamab Market Share by Application in 2023
Figure 28. Global Amivantamab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Amivantamab Sales Market Share by Region (2019-2024)
Figure 30. North America Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Amivantamab Sales Market Share by Country in 2023
Figure 32. U.S. Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Amivantamab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Amivantamab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Amivantamab Sales Market Share by Country in 2023
Figure 37. Germany Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Amivantamab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Amivantamab Sales Market Share by Region in 2023
Figure 44. China Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Amivantamab Sales and Growth Rate (Kilotons)
Figure 50. South America Amivantamab Sales Market Share by Country in 2023
Figure 51. Brazil Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Amivantamab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Amivantamab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Amivantamab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Amivantamab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Amivantamab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Amivantamab Market Share Forecast by Type (2025-2030)
Figure 65. Global Amivantamab Sales Forecast by Application (2025-2030)
Figure 66. Global Amivantamab Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Amivantamab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Amivantamab Market Size (M USD), 2019-2030
Figure 5. Global Amivantamab Market Size (M USD) (2019-2030)
Figure 6. Global Amivantamab Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Amivantamab Market Size by Country (M USD)
Figure 11. Amivantamab Sales Share by Manufacturers in 2023
Figure 12. Global Amivantamab Revenue Share by Manufacturers in 2023
Figure 13. Amivantamab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Amivantamab Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Amivantamab Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Amivantamab Market Share by Type
Figure 18. Sales Market Share of Amivantamab by Type (2019-2024)
Figure 19. Sales Market Share of Amivantamab by Type in 2023
Figure 20. Market Size Share of Amivantamab by Type (2019-2024)
Figure 21. Market Size Market Share of Amivantamab by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Amivantamab Market Share by Application
Figure 24. Global Amivantamab Sales Market Share by Application (2019-2024)
Figure 25. Global Amivantamab Sales Market Share by Application in 2023
Figure 26. Global Amivantamab Market Share by Application (2019-2024)
Figure 27. Global Amivantamab Market Share by Application in 2023
Figure 28. Global Amivantamab Sales Growth Rate by Application (2019-2024)
Figure 29. Global Amivantamab Sales Market Share by Region (2019-2024)
Figure 30. North America Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Amivantamab Sales Market Share by Country in 2023
Figure 32. U.S. Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Amivantamab Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Amivantamab Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Amivantamab Sales Market Share by Country in 2023
Figure 37. Germany Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Amivantamab Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Amivantamab Sales Market Share by Region in 2023
Figure 44. China Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Amivantamab Sales and Growth Rate (Kilotons)
Figure 50. South America Amivantamab Sales Market Share by Country in 2023
Figure 51. Brazil Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Amivantamab Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Amivantamab Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Amivantamab Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Amivantamab Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Amivantamab Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Amivantamab Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Amivantamab Market Share Forecast by Type (2025-2030)
Figure 65. Global Amivantamab Sales Forecast by Application (2025-2030)
Figure 66. Global Amivantamab Market Share Forecast by Application (2025-2030)
